Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival

Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival

Abstract To evaluate tumor blood flow using 15O-water positron emission tomography (PET) in patients with non-small cell lung cancer (NSCLC) before and after chemotherapy with bevacizumab, and to investigate the effects of bevacizumab on tumor blood flow changes and progression-free survival (PFS)....

Full description

Bibliographic Details
Main Authors: Daisuke Katayama, Masahiro Yanagawa, Keiko Matsunaga, Hiroshi Watabe, Tadashi Watabe, Hiroki Kato, Takashi Kijima, Yoshito Takeda, Atsushi Kumanogoh, Eku Shimosegawa, Jun Hatazawa, Noriyuki Tomiyama
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-86405-w

Internet

https://doi.org/10.1038/s41598-021-86405-w

Similar Items